2009 Annual Report and Notice

RNS Number : 2571J

Hutchison China Meditech Limited

29 March 2010

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

2009 Annual Report and

Notice of Annual General Meeting

London: Monday, 29 March 2010: Chi-Med today announces that its 2009 Annual Report together with the Notice of Annual General Meeting and the Proxy Form have been posted to shareholders.  The documents can be accessed from the website of Chi-Med (www.chi-med.com).

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone: [phone] [phone] [phone]
Lazard & Co., Ltd. Paul Gismondi Nick Fowler	Telephone: [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

MSCBBGDXGSDBGGL